Synapse - Andrew Seidman

Results (318)

Characteristics and prognostic factors for patients with HER2-overexpressing breast cancer and brain metastases in the era of HER2-targeted therapy: An argument for earlier detection

Journal Article

Morikawa, A.; Wang, R.; Patil, S.; Diab, A.; Yang, J.; Hudis, C. A.; McArthur, H. L.; Beal, K.; Seidman, A. D.
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients

Journal Article

Bao, T.; Seidman, A. D.; Piulson, L.; Vertosick, E.; Chen, X.; Vickers, A. J.; Blinder, V. S.; Zhi, W. I.; Li, Q.; Vahdat, L. T.; more...
European Journal of Cancer (2018)

Fulltext@MSK | Save

Living with chronic pain: Perceptions of breast cancer survivors

Journal Article

Bao, T.; Seidman, A.; Li, Q.; Seluzicki, C.; Blinder, V.; Meghani, S. H.; Farrar, J. T.; Mao, J. J.
Breast Cancer Research and Treatment (2018)

Fulltext@MSK | Save

ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC)

Meeting Abstract

Tripathy, D.; Sara, T.; Seidman, A. D.; Anders, C. K.; Ibrahim, N.; Rugo, H. S.; Twelves, C. J.; Diéras, V.; Müller, V.; Hannah, A.; more...
Cancer Research (2018)

Fulltext@MSK | Save

An important step forward for biosimilars in cancer treatment

Journal Article

Schleicher, S. M.; Seidman, A. D.
JAMA Oncology (2017)

Fulltext@MSK | Save

Summary of head-to-head comparisons of patient (pt) risk classifications by the 21-gene recurrence score (RS) assay and other genomic assays for early breast cancer (EBC)

Meeting Abstract

Varga, Z.; Sinn, P.; McCullough, D.; Lau, A.; Stöppler, M. C.; Baehner, F. L.; Chao, C.; Seidman, A.
Annals of Oncology (2017)

Fulltext@MSK | Save

Best practices for genomic assay testing in early-stage breast cancer: Clinical and medicolegal perspectives

Journal Article

Seidman, A. D.; Amjadi, D. K.; De La Melena, T.; Wheeler, D.
Population Health Management (2017)

Fulltext@MSK | Save

"A tool, not a crutch': Patients with breast cancers' perceptions of the IBM Watson for Oncology clinical decision support system

Meeting Abstract

Hamilton, J. G.; Shuk, E.; Westerman, J. S.; Genoff, M. C.; Werk, R. S.; Pocus, V.; Hay, J. L.; Walters, C.; Elkin, E.; Gucalp, A.; more...
Annals of Behavioral Medicine (2017)

Fulltext@MSK | Save

Phase 3 study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer who have stable brain metastases previously treated with an anthracycline, a taxane, and capecitabine